Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.
|Grade||Last Price||% Change||$ Change|
ACHN closed down 0.79 percent on Friday, March 24, 2017, on 83 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Trend Table & Recent Alerts
|See historical ACHN trend table...|
|Date||Alert Name||Type||% Chg|
|Mar 24||New Downtrend||Bearish||0.00%|
|Mar 24||Lower Bollinger Band Walk||Other||0.00%|
|Mar 23||Stochastic Reached Oversold||Other||-0.79%|
|Mar 23||Bollinger Band Squeeze||Range Contraction||-0.79%|
|Mar 23||Lower Bollinger Band Walk||Other||-0.79%|
|Mar 22||Bollinger Band Squeeze||Range Contraction||-2.84%|
|Mar 21||Bollinger Band Squeeze||Range Contraction||-2.08%|
|Mar 20||Bollinger Band Squeeze||Range Contraction||-6.23%|
|Mar 17||Bollinger Band Squeeze||Range Contraction||-5.76%|
|Mar 14||NR7||Range Contraction||-5.05%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The companys drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Is ACHN a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACHN news...
|52 Week High||10.06|
|52 Week Low||3.75|
|200-Day Moving Average||6.2671|
|50-Day Moving Average||4.1326|
|20-Day Moving Average||4.001|
|10-Day Moving Average||3.939|
|Average True Range||0.1644|
|Chandelier Exit (Long, 3 ATRs)||3.7868|
|Chandelier Exit (Short, 3 ATRs)||4.2432|
|Upper Bollinger Band||4.2132|
|Lower Bollinger Band||3.7888|
|Percent B (%b)||-0.07|